Drug intelligence / Profile preview

calcitonin gene-related peptide 8-38

Development stage
Unknown
Modality
Peptides
Administration
Intravenous, Intrathecal, Intracerebroventricular
01

Overview

Calcitonin gene-related peptide 8-38 (CGRP 8-38) is a truncated peptide fragment consisting of amino acids 8 through 38 of the full-length CGRP molecule. It functions as a potent and competitive antagonist at the CGRP receptor, which is a heterodimeric G protein-coupled receptor complex comprising the calcitonin receptor-like receptor (CLR) and the receptor activity-modifying protein 1 (RAMP1). By binding to the receptor's orthosteric site without inducing signal transduction, CGRP 8-38 effectively blocks the vasodilatory and pro-nociceptive actions of endogenous CGRP. Although it has been a fundamental pharmacological tool for decades in characterizing CGRP-mediated pathways in migraine, pain, and cardiovascular research, its therapeutic development was hindered by rapid enzymatic degradation and poor oral bioavailability. These limitations eventually led to the clinical development of more stable small-molecule antagonists (gepants) and monoclonal antibodies targeting the CGRP pathway.

Other names
CGRP fragment 8-38Calcitonin gene-related peptide (8-38) human8-38-Calcitonin gene-related peptide
02

Targets

AMY (Pancreatic alpha-amylase)CALCR (Calcitonin receptor)Calcitonin gene-related peptide type 1 receptor

Beyond the preview

Go deeper on calcitonin gene-related peptide 8-38.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcitonin gene-related peptide 8-38.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call